Form PREC14A - Preliminary proxy statements, contested solicitations:
SEC Accession No. 0001193125-16-528057
Filing Date
2016-04-01
Accepted
2016-04-01 16:59:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 PREC14A d52279dprec14a.htm PREC14A 422550
  Complete submission text file 0001193125-16-528057.txt   424405
Mailing Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011
Business Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 425-686-1500
ONCOGENEX PHARMACEUTICALS, INC. (Filed by) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011
Business Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 425-686-1500
ONCOGENEX PHARMACEUTICALS, INC. (Subject) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A | Act: 34 | File No.: 033-80623 | Film No.: 161547919
SIC: 2835 In Vitro & In Vivo Diagnostic Substances